Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

US Patent 7638510 · Granted Dec 29, 2009

Estimated economic value: $22,619,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine recept2025
Bifidobacterium longum for treating obesity and weight management2023
Compositions comprising bacterial strains2022
Compositions comprising bacterial strains2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Probiotic Bifidobacterium strain2022
Bifidobacterium longum NCIMB 416762020
Probiotic bifidobacterium strain2020
Probiotic bifidobacterium strain2018
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2017
Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-be2016